Douglas Helm, MD
Plastic Surgery · Weymouth, MANPI 1598827933
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $900 of the $1,168 with a category attached, or 77.0%. W. L. Gore & Associates, Inc. accounts for 77.0% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $919, more than ten times the $60 reported in 2020.
Across 15 payments — averaging $77.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$900
- Mentor Worldwide LLC$135
- Sientra, Inc.$71
- Integra Lifesciences Corporation$25
- KCI USA, Inc.$22
- Galderma Laboratories, L.p.$15
What the payments were for
- Speaking & faculty fees$90077%
- Food & beverage$26823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 1 | $900 |
| Mentor Worldwide LLC | 7 | $135 |
| Sientra, Inc. | 4 | $71 |
| Integra Lifesciences Corporation | 1 | $25 |
| KCI USA, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,168 in reported general payments places this provider in the 60th percentile of 113 plastic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $109 |
| Cephalexin | 16 | $64 |
| Oxycodone Hcl | 11 | $21 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Weymouth
- William AustenBoston$150K
- Daniel DelvecchioBoston$141K
- Edward KobraeiBoston$78K
- Samuel LinBoston$72K
- Michael TantilloChestnut Hill$71K
- Katherine CarruthersBoston$55K
- Vickram TandonJamaica Plain$51K
- Sean DohertyBrookline$35K
- Jonathan MillerSpringfield$26K
- Swapnil KachareBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.